Mehran Contrast Nephropathy Risk Score: Is It Still Useful 10 Years Later?

Journal of Cardiology - Japan
doi 10.1016/j.jjcc.2015.05.007
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Still Asking “Which Rate Is Right?” Years Later

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2018English

Mehran and AGEF Risk Scores in Contrast-Induced Nephropathy Among Patients Undergoing Primary Percutaneous Coronary Intervention

The Medical Journal of Cairo University
2018English

Rascal, 10 Years Later

2019English

Halloween Costume Party Still Going 20 Years Later

Special Events Galore
2019English

Anacapa Rat Eradication 10 Years Later

Proceedings of the Vertebrate Pest Conference
2014English

An Imperfect Model Is Still Useful

Addiction
MedicinePsychiatryMental Health
2019English

Contrast-Induced Nephropathy: How It Develops, How to Prevent It.

Cleveland Clinic Journal of Medicine
Medicine
2006English

Is the ABCD Score Truly Useful?

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2006English

Use of Cerebral Revascularization Techniques in the Endovascular Era. Is It Still a Useful Technique?

SN Comprehensive Clinical Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy